HF
SCPH

HRT Financial’s scPharmaceuticals SCPH Stock Holding History

HRT Financial’s Portfolio SCPH Stock Details SCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-40,667
Closed -$154K – 3650
2025
Q2 		$154K Buy
+40,667
New +$126K ﹤0.01% 2130
2023
Q2 		– Sell
-65,198
Closed -$591K – 3210
2023
Q1 		$591K Buy
+65,198
New +$478K 0.01% 1246
2021
Q4 		– Sell
-16,189
Closed -$107K – 4017
2021
Q3 		$107K Sell
16,189
-4,072
-20% -$24.3K ﹤0.01% 2882
2021
Q2 		$123K Buy
+20,261
New +$122K ﹤0.01% 2540

Other funds holding SCPH

O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $8.16B AUM 68.42% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $5.43B AUM 42.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $18.6B AUM 29.12% 1-Year Est. Return
Luther King Capital Management (LKCM)
Luther King Capital Management (LKCM) Fort Worth, Texas $23.1B AUM 21.31% 1-Year Est. Return
HSBC Holdings
HSBC Holdings London, United Kingdom $168B AUM 27.2% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return